Aligos Therapeutics, Inc. (ALGS)
8.01
+0.07
(+0.88%)
USD |
NASDAQ |
Jan 20, 16:00
8.03
+0.02
(+0.25%)
After-Hours: 20:00
Aligos Therapeutics Market Cap: 49.29M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 525.73B |
| CEL-SCI Corp. | 15.93M |
| AIM ImmunoTech, Inc. | 3.471M |
| IGC Pharma, Inc. | 26.01M |
| NovaBay Pharmaceuticals, Inc. | 820.13M |
Market Cap Related Metrics
| PS Ratio | 27.03 |
| PEG Ratio | -0.0084 |
| Price to Book Value | 0.6862 |
| Price | 8.01 |
| Earnings Yield | -246.7% |
| PEGY Ratio | -0.0084 |